Quantitative Investment Management, LLC Alaunos Therapeutics, Inc. Transaction History

Quantitative Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.63 - $3.67 $60,158 - $83,947	-22,874 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.82 - $5.6 $64,504 - $128,094	22,874 New	22,874 $82,000
Q2 2020 Aug 14, 2020	SELL	$2.2 - $3.71 $193,806 - $326,828	-88,094 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.9 - $4.98 $147,571 - $386,791	77,669 Added 745.03%	88,094 $215,000
Q4 2019 Feb 14, 2020	SELL	$3.95 - $5.35 $684,902 - $927,652	-173,393 Reduced 94.33%	10,425 $49,000
Q3 2019 Nov 14, 2019	BUY	$4.13 - $6.94 $759,168 - $1.28 Million	183,818 New	183,818 $786,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $422M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Investment Management, LLC with notifications on news.